<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordOutput id="3773"><DrugName>Org-4094</DrugName><DrugSynonyms><Name><Value>Org-4094</Value><Types><Type>Research Code</Type></Types></Name><Name><Value>100239-45-0</Value><Types><Type>CAS RN</Type></Types></Name></DrugSynonyms><CompanyOriginator id="13880">MSD OSS BV</CompanyOriginator><CompaniesSecondary><Company id="13880">MSD OSS BV</Company></CompaniesSecondary><CrossReferences><SourceEntity id="3773" type="Drug"><TargetEntity id="193863" type="siDrug">Org-4094</TargetEntity></SourceEntity><SourceEntity id="13880" type="Company"><TargetEntity id="4298331728" type="organizationId">Organon Biosciences BV</TargetEntity></SourceEntity><SourceEntity id="36" type="ciIndication"><TargetEntity id="10061664" type="MEDDRA"/><TargetEntity id="D001327" type="MeSH"/><TargetEntity id="-2072222280" type="omicsDisease"/><TargetEntity id="729" type="siCondition"/></SourceEntity></CrossReferences><PhaseHighest id="DX">Discontinued</PhaseHighest><IndicationsSecondary><Indication id="36">Autoimmune disease</Indication></IndicationsSecondary><ActionsSecondary><Action id="59620">Unspecified drug target</Action><Action id="396">Immunosuppressant</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><EphmraCodes><Ephmra><Code>L4</Code><Name>IMMUNOSUPPRESSIVE AGENTS</Name></Ephmra></EphmraCodes><LastModificationDate>2017-09-02T10:51:54.000Z</LastModificationDate><ChangeDateLast>1999-07-23T15:20:10.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;&lt;ulink linkID="3773" linkType="Drug"&gt;Org-4094&lt;/ulink&gt; is an immunosuppressant which was being investigated by Organon as a potential treatment for autoimmune disease [&lt;ulink linkID="164315" linkType="reference"&gt;164315&lt;/ulink&gt;].&lt;/para&gt;&lt;para&gt;This compound was not included in &lt;ulink linkID="13802" linkType="Company"&gt;Akzo Nobel&lt;/ulink&gt; Pharma's 1996 product pipeline and was presumed to have been dropped from development. This was confirmed by a company spokesperson in July 1999 [&lt;ulink linkID="333741" linkType="reference"&gt;333741&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="13880">MSD OSS BV</Company><Country id="NL">Netherlands</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="4">Not Reported</DiscontinuedReason><Indication id="36">Autoimmune disease</Indication></DevelopmentStatusCurrent></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate></ReasonsForUpdate><StructureSmiles><Smiles>C[C@@H]1CC2=C(CC[C@@H](C2)O)[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O</Smiles></StructureSmiles><hasSWOTs>N</hasSWOTs></drugRecordOutput>